• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

    4/15/24 5:45:11 AM ET
    $AEYE
    $ALLR
    $BPTS
    $CYN
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEYE alert in real time by email

    Shares of Medical Properties Trust, Inc. (NYSE:MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.

    Medical Properties Trust shares jumped 13.1% to $4.51 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares rose 51% to $3.17 in pre-market trading after dipping 9% on Friday. Allarity Therapeutics filed prospectus supplement to increase offering price of common stock that may be offered from $2.35 million to $3.2 million.
    • Longeveron Inc. (NASDAQ:LGVN) gained 38.4% to $2.34 in pre-market trading after falling 16% on Friday. Longeveron, last week, announced closing of $5.2 million public offering.
    • SuperCom Ltd. (NASDAQ:SPCB) shares gained 34.8% to $0.3722 in pre-market trading after jumping around 18% on Friday.
    • HUB Cyber Security Ltd. (NASDAQ:HUBC) climbed 29.2% to $1.68 in pre-market trading after gaining over 11% on Friday.
    • Piedmont Lithium Inc. (NYSE:PLL) shares gained 22.2% to $15.49 in pre-market trading following a 5% decline on Friday.
    • Marine Petroleum Trust (NASDAQ:MARPS) gained 12.3% to $6.04 in pre-market trading after jumping 18% on Friday.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) shares gained 11.4% to $32.31 in pre-market trading after dipping 42% on Friday.
    • Kineta, Inc. (NASDAQ:KA) shares rose 8.7% to $0.3989 in pre-market trading after falling 17% on Friday.
    • LendingClub Corporation (NYSE:LC) shares gained 8.7% to $8.79 in pre-market trading. LendingClub is expected to report earnings for the first quarter 2024 after the closing bell on Tuesday, April 30, 2024.


    Losers

    • AudioEye, Inc. (NASDAQ:AEYE) fell 24.1% to $10.45 in pre-market trading after declining around 7% on Friday.
    • NextPlat Corp (NASDAQ:NXPL) fell 19.8% to $1.50 in pre-market trading after jumping 24% on Friday. The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc.
    • Organovo Holdings Inc (NASDAQ:ONVO) shares declined 15.8% to $0.85 in pre-market trading.
    • TRACON Pharmaceuticals Inc (NASDAQ:TCON) declined 15.3% to $2.00 in pre-market trading after falling around 9% on Friday.
    • IM Cannabis Corp (NASDAQ:IMCC) fell 14.2% to $0.54 in pre-market trading.
    • OncoCyte Corp (NASDAQ:OCX) fell 14.1% to $2.33 pre-market trading. Oncocyte announced a transplant assay partnership agreement with Bio-Rad laboratories
    •  
    • Cyngn Inc (NASDAQ:CYN) shares fell 13.6% to $0.12 in pre-market trading after declining around 7% on Friday.
    • SINTX Technologies Inc (NASDAQ:SINT) fell 12.6% to $0.021 in pre-market trading after declining around 4% on Friday.
    •  
    • Biophytis SA (NASDAQ:BPTS) shares fell 7.4% to $0.31 in pre-market trading.
    • Polestar Automotive Holding Uk Plc (NASDAQ:PSNY) fell 7.2% to $1.35 pre-market trading. On Friday, Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $5 price target.

     

    Now Read This: Goldman Sachs Likely To Report Lower Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

    Get the next $AEYE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEYE
    $ALLR
    $BPTS
    $CYN

    CompanyDatePrice TargetRatingAnalyst
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    LendingClub Corporation
    $LC
    11/10/2025$23.00Mkt Perform → Mkt Outperform
    Citizens JMP
    LendingClub Corporation
    $LC
    10/23/2025$22.00Neutral → Overweight
    Analyst
    Allarity Therapeutics Inc.
    $ALLR
    7/28/2025$9.00Buy
    Ascendiant Capital Markets
    LendingClub Corporation
    $LC
    7/7/2025Mkt Perform
    Citizens JMP
    LendingClub Corporation
    $LC
    6/12/2025$15.00Overweight
    Stephens
    Oncocyte Corporation
    $OCX
    3/28/2025$5.00Buy
    Lake Street
    Medical Properties Trust Inc.
    $MPW
    3/12/2025$5.00 → $9.00Neutral → Outperform
    Exane BNP Paribas
    More analyst ratings

    $AEYE
    $ALLR
    $BPTS
    $CYN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Polestar Automotive Holding UK PLC downgraded by Cantor Fitzgerald

    Cantor Fitzgerald downgraded Polestar Automotive Holding UK PLC from Neutral to Underweight

    2/19/26 7:50:28 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Lending Club upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Lending Club from Mkt Perform to Mkt Outperform and set a new price target of $23.00

    11/10/25 8:34:33 AM ET
    $LC
    Finance: Consumer Services
    Finance

    Lending Club upgraded by Analyst with a new price target

    Analyst upgraded Lending Club from Neutral to Overweight and set a new price target of $22.00

    10/23/25 6:59:33 AM ET
    $LC
    Finance: Consumer Services
    Finance

    $AEYE
    $ALLR
    $BPTS
    $CYN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF FINANCIAL OFFICER Georgevich Kelly bought $99,398 worth of shares (16,850 units at $5.90), increasing direct ownership by 13% to 144,981 units (SEC Form 4)

    4 - AUDIOEYE INC (0001362190) (Issuer)

    3/17/26 4:35:45 PM ET
    $AEYE
    Computer Software: Prepackaged Software
    Technology

    Director Hawkins James B bought $219,744 worth of shares (38,000 units at $5.78), increasing direct ownership by 22% to 207,517 units (SEC Form 4)

    4 - AUDIOEYE INC (0001362190) (Issuer)

    3/12/26 4:20:55 PM ET
    $AEYE
    Computer Software: Prepackaged Software
    Technology

    Director Lyons Christopher Michael bought $24,092 worth of shares (8,292 units at $2.91) (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    3/10/26 9:00:18 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $AEYE
    $ALLR
    $BPTS
    $CYN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Polestar Automotive Holding UK PLC

    SCHEDULE 13D/A - Polestar Automotive Holding UK PLC (0001884082) (Subject)

    3/18/26 4:30:59 PM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Cyngn Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Cyngn Inc. (0001874097) (Filer)

    3/17/26 4:30:26 PM ET
    $CYN
    EDP Services
    Technology

    SEC Form 6-K filed by IM Cannabis Corp.

    6-K - IM Cannabis Corp. (0001792030) (Filer)

    3/17/26 4:03:41 PM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care

    $AEYE
    $ALLR
    $BPTS
    $CYN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Trabelsi Arie

    3 - SuperCom Ltd (0001291855) (Issuer)

    3/18/26 6:07:17 PM ET
    $SPCB
    Semiconductors
    Technology

    SEC Form 3 filed by new insider Engstrom Jonas Hakan

    3 - Polestar Automotive Holding UK PLC (0001884082) (Issuer)

    3/18/26 3:40:05 PM ET
    $PSNY
    Auto Manufacturing
    Industrials

    SEC Form 3 filed by new insider Dicken Scott Fraser

    3 - Polestar Automotive Holding UK PLC (0001884082) (Issuer)

    3/18/26 3:37:35 PM ET
    $PSNY
    Auto Manufacturing
    Industrials

    $AEYE
    $ALLR
    $BPTS
    $CYN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SuperCom Wins $17 Million National Electronic Monitoring Contract in Sweden

    Highest score in five-company competitive bid process expands SuperCom's national presence in Sweden, representing 6x expected growth over the prior projectFurther expansion opportunities remain for additional programs of substantial size such as alcohol monitoring TEL AVIV, Israel, March 19, 2026 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, is pleased to announce it has been awarded a new national electronic monitoring (EM) contract by Sweden's Prison and Probation Service. The win marks SuperCom's fourth contract win in the country since its entry. Under the contract, SuperCom will deploy its PureSecur

    3/19/26 9:00:00 AM ET
    $SPCB
    Semiconductors
    Technology

    SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

    Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform SALT LAKE CITY, Utah, March 19, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced ceramic biomaterials and silicon nitride medical device innovation, today announced the successful completion of the first-in-human surgical procedure utilizing its FDA-cleared SINAPTIC® Foot & Ankle Osteotomy Wedge System, marking a major clinical and commercial milestone in the Company's expansion into the global orthopedic device market. The procedure represents SINTX's entry int

    3/19/26 7:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

    On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indicationELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacyClosed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused fundsCompany to host conference call and webcast today at 4:30 p.m. ET MIAMI, March 17

    3/17/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEYE
    $ALLR
    $BPTS
    $CYN
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

    Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX Technologies, Inc., effective March 16, 2026. Mr. Elmore most recently served as Core Business Director at Invibio, a division of Victrex plc. With more than 15 years of experience in advanced biomaterials and medical dev

    2/18/26 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Polestar starts largest model offensive in its history: four new cars in three years

    Polestar 5 to start deliveries in summer, followed by a new variant of Polestar 4 in Q4 of 2026 Completely new successor of the iconic Polestar 2 in 2027 and compact SUV Polestar 7 in 2028 Michael Lohscheller, Polestar CEO: "Polestar continues to challenge the automotive industry, now by entering fast-growing and high value segments in record speed." Polestar (NASDAQ:PSNY) today announced the largest model offensive in its history, with four new cars planned in the next three years. The Company also announced that with a disciplined approach, in 2026 it expects low double-digit volume growth and a continued retail network expansion of 30%. This press release features multimedia.

    2/18/26 6:00:00 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    $AEYE
    $ALLR
    $BPTS
    $CYN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Oncocyte Corporation

    SC 13G/A - Oncocyte Corp (0001642380) (Subject)

    12/9/24 5:30:06 PM ET
    $OCX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by TRACON Pharmaceuticals Inc.

    SC 13G/A - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

    11/14/24 8:51:58 PM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by SiNtx Technologies Inc.

    SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

    11/14/24 7:25:52 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $AEYE
    $ALLR
    $BPTS
    $CYN
    Financials

    Live finance-specific insights

    View All

    Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

    On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indicationELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacyClosed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused fundsCompany to host conference call and webcast today at 4:30 p.m. ET MIAMI, March 17

    3/17/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026

    MIAMI, March 12, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report 2025 full year financial results and provide a business update on Tuesday, March 17, 2026 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET. Conference Call and Webcast Details: Conference Call Number:1.877.407.0789Conference ID:13758462  Call meTM Feature:Click HereWebcast:Click Here   An archived replay of the webcast will be available on the "Events & Presentations" sec

    3/12/26 9:00:00 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AudioEye Reports Record Fourth Quarter and Full Year 2025 Results

    Fortieth Consecutive Period of Record RevenueTUCSON, Ariz., March 5, 2026 /PRNewswire/ -- AudioEye, Inc. (NASDAQ:AEYE) ("AudioEye" or the "Company"), the industry-leading digital accessibility company, reported financial results for the fourth quarter and full year ended December 31, 2025. David Moradi, CEO of AudioEye, commented: "We delivered an exceptional fourth quarter with strong ARR growth to close out a record year for AudioEye. Full year 2025 revenue grew 15% to $40.3 million, net loss decreased 28% to $3.1 million, and adjusted EBITDA grew 35% to $9.1 million. For 2026

    3/5/26 4:01:00 PM ET
    $AEYE
    Computer Software: Prepackaged Software
    Technology